Study Information

Title: A Dose Escalation and Cohort Expansion Study of TEN-010 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome External
Status: Recruiting participants
Conditions: Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS)
Interventions: Drug: TEN-010
Institutions: Dana-Farber Cancer Institute
Health Topics: Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes

Contact Information


Dana Farber Cancer Institute (DFCI)
Boston, MA 02115
Caroline Kokulis
617-632-6288